Cyclosporine in addition to infliximab and methotrexate in refractory rheumatoid arthritis.
Marchesoni
A
A
Sarzi Puttini
P
P
Gorla
R
R
Caporali
R
R
Arnoldi
C
C
Atzeni
F
F
Vianelli
M
M
Pallavicini
F Bobbio
FB
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D016572:Cyclosporine; D000069285:Infliximab; D008727:Methotrexate